{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.80",
    "chg": -4.19,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "83.99",
    "mcapval": "201.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "8.11 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4002904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_4002904.png",
        "date": "2026-05-21 10:10:05",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3984138",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NovelixPharmace_mojoScore_3984138.png",
        "date": "2026-05-10 10:10:02",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-3952127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NovelixPharmace_mojoScore_3952127.png",
        "date": "2026-04-18 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 14,
    "sid": "200695",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Jun-2026",
      "details": "Newspaper Publication for intimation of special window.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "10-Jun-2026",
      "details": "Newspaper Publication EGM Notice.",
      "source": "BSE"
    },
    {
      "caption": "Shareholders Meeting- Notice Of Extra-Ordinary General Meeting Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "09-Jun-2026",
      "details": "Notice of Extra Ordinary General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-21 10:10:05

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read More

Novelix Pharmaceuticals Ltd is Rated Hold

2026-05-10 10:10:02

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with the latest insights into its performance and outlook.

Read More

Novelix Pharmaceuticals Ltd is Rated Hold

2026-04-18 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read More

View All News